Ageing and Neurodegeneration

Ageing and neurodegeneration are closely interconnected processes that significantly impact human health and well-being. As individuals age, the risk of developing neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's increases. Neurodegeneration refers to the progressive loss of structure or function of neurons, leading to cognitive decline, motor impairment, and ultimately, loss of independence. Several factors contribute to ageing-related neurodegeneration. One primary mechanism is the accumulation of abnormal protein aggregates within neurons, disrupting cellular function and leading to cell death. For example, in Alzheimer's disease, beta-amyloid plaques and tau tangles accumulate in the brain, interfering with neuronal communication and causing memory loss and cognitive decline. Additionally, oxidative stress and inflammation play significant roles in both ageing and neurodegeneration. Over time, cells accumulate damage from reactive oxygen species, leading to impaired cellular function and increased vulnerability to neurodegenerative processes. Chronic inflammation in the brain exacerbates neuronal damage and accelerates neurodegenerative diseases' progression. Genetic predispositions also influence the risk of neurodegeneration with age. Certain genetic mutations increase susceptibility to neurodegenerative diseases, often affecting protein processing or cellular maintenance mechanisms. Understanding the complex interplay between ageing and neurodegeneration is crucial for developing effective interventions and treatments. Research into lifestyle factors, such as diet, exercise, and cognitive stimulation, shows promise in slowing cognitive decline and reducing neurodegenerative disease risk in ageing populations. Additionally, targeted therapies aimed at clearing abnormal protein aggregates or modulating inflammatory processes offer hope for mitigating the impact of neurodegeneration on ageing individuals' quality of life.